TABLE 3.
MFI reduction at | HLA I & II | ||||||
| |||||||
t-point 2 from
t-point 1 value |
2.7* | ||||||
| |||||||
HLA Class | I | II | |||||
| |||||||
t-point 2 from
t-point 1 value |
8.8* | −2.3 | |||||
| |||||||
HLA Specificity | A | B | C | DR51-53 | Other DR | DQ | DP |
| |||||||
t-point 2 from
t-point 1 value |
10.5** | 16.3** | 3.3 | −28.8 | 8.2 | −4.2 | 14.8** |
p < 0.005,
p < 0.05.
t-point 1: after one to three TPE treatments.
t-point 2: after four to six TPE treatments.